Association of the STAT4, CDKN1A, and IRF5 variants with risk of lupus nephritis and renal biopsy classification in patients in Vietnam
- PMID: 33687153
- PMCID: PMC8123735
- DOI: 10.1002/mgg3.1648
Association of the STAT4, CDKN1A, and IRF5 variants with risk of lupus nephritis and renal biopsy classification in patients in Vietnam
Abstract
Background: Lupus nephritis is a common complication of systemic lupus erythematosus (SLE, OMIM #15200) in the Asian population and a main contributor to mortality and morbidity. In this study, we evaluate the variants on three genes STAT4, CDKN1A, and IRF5 and their association with lupus nephritis.
Method: One hundred fifty-two SLE patients with confirmed lupus nephritis (through biopsy) and 76 healthy controls were recruited. Genotyping of SNPs on three gene STAT4, CDKN1A, and IRF5, phenotypic, and laboratory assessment were performed; renal biopsy and classification were carried out for the patient group.
Results: Carriers of rs7582694 C alleles on STAT4 have higher risk of lupus nephritis (OR 2.0; 95% CI [1.14, 3.19]; p = 0.015), at higher risk of hematuria and higher serum level of dsDNA antibodies compared to controls (p < 0.05) and were more likely to have nephrotic histopathology grading of class III or higher. No association was observed for CDKN1A; and no variation was observed for the IRF5 gene in both the study and control group.
Conclusion: This study investigates the relationship between STAT4, CDKN1A, and IRF5 gene and SLE in a Vietnamese patient population. Patients with the C allele (STAT4) in rs7582694 were associated with a more severe disease phenotype.
Keywords: CDKN1A; IRF5; STAT4; SLEDAI; risk factor; systemic lupus erythematous.
© 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis.PLoS One. 2013 Dec 27;8(12):e84450. doi: 10.1371/journal.pone.0084450. eCollection 2013. PLoS One. 2013. PMID: 24386384 Free PMC article. Clinical Trial.
-
Genetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap.PLoS One. 2010 May 10;5(5):e10559. doi: 10.1371/journal.pone.0010559. PLoS One. 2010. PMID: 20479942 Free PMC article.
-
A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.Hum Mol Genet. 2008 Sep 15;17(18):2868-76. doi: 10.1093/hmg/ddn184. Epub 2008 Jun 25. Hum Mol Genet. 2008. PMID: 18579578 Free PMC article.
-
Association of IRF5, STAT4 and BLK with systemic lupus erythematosus and other rheumatic diseases.Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(2):57-65. doi: 10.2177/jsci.33.57. Nihon Rinsho Meneki Gakkai Kaishi. 2010. PMID: 20453440 Review.
-
Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis.Int J Dermatol. 2016 Apr;55(4):408-16. doi: 10.1111/ijd.12839. Epub 2015 Dec 29. Int J Dermatol. 2016. PMID: 26712637 Review.
Cited by
-
Deciphering the Genetic Code of Autoimmune Kidney Diseases.Genes (Basel). 2023 Apr 30;14(5):1028. doi: 10.3390/genes14051028. Genes (Basel). 2023. PMID: 37239388 Free PMC article. Review.
-
SDMA attenuates renal tubulointerstitial fibrosis through inhibition of STAT4.J Transl Med. 2023 May 16;21(1):326. doi: 10.1186/s12967-023-04181-9. J Transl Med. 2023. PMID: 37194066 Free PMC article.
-
IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis.Front Immunol. 2021 Apr 20;12:676082. doi: 10.3389/fimmu.2021.676082. eCollection 2021. Front Immunol. 2021. PMID: 33959133 Free PMC article. Review.
-
Transcription Factors in the Pathogenesis of Lupus Nephritis and Their Targeted Therapy.Int J Mol Sci. 2024 Jan 16;25(2):1084. doi: 10.3390/ijms25021084. Int J Mol Sci. 2024. PMID: 38256157 Free PMC article. Review.
-
Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients.Clin Rheumatol. 2024 Aug;43(8):2403-2416. doi: 10.1007/s10067-024-07046-8. Epub 2024 Jul 4. Clin Rheumatol. 2024. PMID: 38963465 Review.
References
-
- Bombardier, C. , Gladman, D. D. , Urowitz, M. B. , Caron, D. , Chang, C. H. , Austin, A. , Bell, A. , Bloch, D. A. , Corey, P. N. , Decker, J. L. , Esdaile, J. , Fries, J. F. , Ginzler, E. M. , Goldsmith, C. H. , Hochberg, M. C. , Jones, J. V. , Riche, N. G. H. L. , Liang, M. H. , Lockshin, M. D. , … Schur, P. H. (1992). Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis and Rheumatism, 35(6), 630–640. 10.1002/art.1780350606 - DOI - PubMed
-
- Doria, A. , Iaccarino, L. , Ghirardello, A. , Zampieri, S. , Arienti, S. , Sarzi‐Puttini, P. , Atzeni, F. , Piccoli, A. , & Todesco, S. (2006). Long‐term prognosis and causes of death in systemic lupus erythematosus. The American Journal of Medicine, 119(8), 700–706. 10.1016/j.amjmed.2005.11.034 - DOI - PubMed
-
- Graham, R. R. , Kyogoku, C. , Sigurdsson, S. , Vlasova, I. A. , Davies, L. R. L. , Baechler, E. C. , Plenge, R. M. , Koeuth, T. , Ortmann, W. A. , Hom, G. , Bauer, J. W. , Gillett, C. , Burtt, N. , Cunninghame Graham, D. S. , Onofrio, R. , Petri, M. , Gunnarsson, I. , Svenungsson, E. , Ronnblom, L. , … Altshuler, D. (2007). Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proceedings of the National Academy of Sciences, 104(16), 6758–6763. 10.1073/pnas.0701266104 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous